Octreotide

N/A

Report date: 2024/08/08 17:09:57

Base Information

Drug NameOctreotide
Drug Alias NameQR-107
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsGastroenteropancreatic neuroendocrine tumorGastrointestinal HemorrhageNeoplasm Metastasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEgyptSpain +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesQrono IncEnteris Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnteris Biopharma IncNational Hepatology & Tropical Medicine Research InstituteUniversity Of Navarra +[5] 
Inactive CompaniesDuke University
Active IndicationsGastroenteropancreatic neuroendocrine tumorGastrointestinal HemorrhageNeoplasm Metastasis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A